Cockroach Labs Valued at 166x Revenue

A 166x revenue multiple means most of Cockroach Labs’s future upside was already priced into the last round, so the next investors need years of extreme growth just to earn a strong return. At roughly $30M of 2021 revenue and a $5B valuation, the company was being valued less like a normal database vendor and more like a candidate to become a category leader on the back of fast cloud adoption, open source distribution, and a sticky multi region database product.

• The gap versus peers was enormous. Cockroach Labs was marked at 166x revenue, compared with about 45x for Snowflake, 14.5x for MongoDB, 4.4x for Oracle, 47.5x for Databricks, and 19x for MariaDB. That leaves much less room for multiple expansion as a driver of venture returns.
  1 sacra
• That premium came from unusual growth. Revenue was estimated to rise from $10M in 2020 to $30M in 2021, or 200% growth, while nearly half of customers were already using the cloud product and cloud revenue was growing faster than the self hosted business.
  2 sacra 3 sacra
• The valuation also affects hiring economics. Late stage recruits are often paid partly in equity, and when the entry price is already very high, new options can feel less valuable unless the company keeps compounding quickly enough to outrun both dilution and a tougher funding market.
  2 sacra

From here, the path to making that price look reasonable is clear. Cockroach Labs has to turn developer adoption into much larger production deployments, shift more revenue into its managed cloud offering, and grow into a scale where it is compared to durable public infrastructure companies rather than judged as a venture priced outlier.